Reuters exclusively reports JPMorgan cuts ties with OxyContin maker Purdue Pharma

Reuters exclusively reported that JPMorgan Chase & Co has cut ties with Purdue Pharma LP over the OxyContin maker’s alleged role in the U.S. opioid crisis, forcing it to find a new bank to manage cash and bill payments. The move makes JPMorgan the most high-profile corporation known to have distanced itself from Purdue and its wealthy owners, the Sackler family.